Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

15.02 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

34 35 Next >

Dow Jumps 300 Points; Crude Oil Rises Sharply ↗

September 28, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Wednesday.

Via Benzinga

Why Is Taiwan Semiconductor (TSM) Stock Down Today? ↗

September 28, 2022

Taiwan Semiconductor (TSM) stock isn't doing so hot Wednesday on reports that Apple (AAPL) is decreasing production for the iPhone 14.

Via InvestorPlace

LYFT Stock Alert: What to Know as Lyft Pumps the Brakes on Hiring ↗

September 28, 2022

Lyft (LYFT) stock is getting a boost on Wednesday after the ride-sharing company revealed a stop to hiring for the rest of the year.

Via InvestorPlace

Why Is MindMed (MNMD) Stock Plunging 51% Today? ↗

September 28, 2022

MNMD stock is tumbling more than 50% after the drug maker announced that it would sell shares of its stock and warrants for its shares.

Via InvestorPlace

US Stocks Mixed; Wholesale Inventories Increase 1.3% In August ↗

September 28, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 20 points on Wednesday.

Via Benzinga

Why MindMed Stock Is Tanking Today ↗

September 28, 2022

Mind Medicine Inc (NASDAQ: MNMD) shares are trading lower Wednesday after the company announced a proposed public offering of common shares.

Via Benzinga

MindMed To Raise Around $30M Via Public Offering ↗

September 28, 2022

Mind Medicine Inc.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 28, 2022

It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.

Via InvestorPlace

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket ↗

September 28, 2022

Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.

Via Benzinga

Cintas, Paychex And 3 Stocks To Watch Heading Into Wednesday ↗

September 28, 2022

With US stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Why Mind Medicine (MindMed) Stock Is Diving After Hours ↗

September 27, 2022

Mind Medicine Inc (NASDAQ: MNMD) shares are trading lower in Tuesday's after-hours session after the company announced a proposed public offering of common shares.

Via Benzinga

Biomind Labs, Allied Among Top Psychedelic Movers Of Today ↗

September 27, 2022

GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 11.10% at $1.10

Via Benzinga

Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

September 26, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.91% at $0.13

Via Benzinga

The 5 Cannabis Categories Fell Even Further Last Week ↗

September 26, 2022

The 5 categories in the cannabis sector performed quite differently from each other again last week. The ones that lost least are the most peripheral to the growing and/or distribution of cannabis.

Via Talk Markets

Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD ↗

September 25, 2022

Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week.

Via Talk Markets

Psychedelic Stock Gainers And Losers From September 22, 2022 ↗

September 22, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.80% at $1.10

Via Benzinga

Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics

September 22, 2022

Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City...

Via PressReach

Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics

September 22, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one...

Via FinancialNewsMedia

Psychedelic Stock Gainers And Losers From September 21, 2022 ↗

September 21, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.87% at $0.32

Via Benzinga

Seelos Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗

September 20, 2022

GAINERS: Allied (OTC:ALID) shares closed up 7.83% at $0.62

Via Benzinga

Clinical Research Comparing Effects Of Novel MDMA Matches In Healthy Patients Begins In Switzerland ↗

September 20, 2022

The clinical trial investigating the effects of MDMA analogs in healthy volunteers led by PI Prof. Dr. Matthias Liechti and supported by psychedelics biotech company Mind Medicine Inc. (NASDAQ:...

Via Benzinga

Psychedelic Stock Gainers And Losers From September 19, 2022 ↗

September 19, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 5.28% at $0.65

Via Benzinga

The 5 Cannabis Categories Declined Between 3% And 11.5% Last Week ↗

September 19, 2022

The cannabis sector consists of 5 distinctly different categories and they each perform quite differently.

Via Talk Markets

8 Largest Psychedelic Stocks Continued Their Decline Last Week ↗

September 18, 2022

The 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index were collectively down 10% in the past week. We also take a look at some therapy-clinic stocks.

Via Talk Markets

Numinus Wellness, GH Research Among Top Psychedelic Movers Of Today ↗

September 15, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 3.98% at $14.64

Via Benzinga

This Psychedelics Company Is Undertaking A 1:50 Reverse Stock Split To Enter NASDAQ ↗

September 15, 2022

The psychedelics landscape changes quickly. Whether large or small, every biotech company is looking for ways to further advance their research and product & services commercialization.

Via Benzinga

GH Research, Cybin Among Top Psychedelic Movers Of Today ↗

September 14, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 9.26% at $13.81

Via Benzinga

CFVI Stock Heats Up Ahead of Rumble SPAC Merger Vote ↗

September 14, 2022

CF Acquisition (CFVI) stock is getting a boost on Wednesday as investors prepare to vote on a SPAC merger with Rumble tomorrow.

Via InvestorPlace

What Is Going on With bioAffinity (BIAF) Stock Today? ↗

September 14, 2022

BioAffinity (BIAF) stock is rising higher on Wednesday after the company announced the publication of its research in 'PLOS ONE'.

Via InvestorPlace

MindMed (MNMD) Stock Regains Nasdaq Compliance ↗

September 14, 2022

MindMed (MNMD) stock is in the news Wednesday after the psychedelic medicine company regained Nasdaq minimum price compliance.

Via InvestorPlace

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.